Robert Greenberg Skechers Usa Inc (SKX) insider trading activity

Robert Greenberg is CHIEF EXECUTIVE OFFICER of SKECHERS USA INC. Currently has a direct ownership of 0 shares of SKX, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 12,396 shares (Class A Common Stock) at a price of $41.95 per share, resulting in proceeds of $520,012. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

ROBERT GREENBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2023	SELL Payment of exercise price or tax liability	$520,012 $41.95 p/Share	12,396 Reduced 6.01%	193,854 Class A Common Stock
Mar 02 2022	SELL Open market or private sale	$3,684,094 $43.3 p/Share	85,083 Reduced 29.2%	206,250 Class A Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$3,473,017 $41.51 p/Share	83,667 Reduced 22.31%	291,333 Class A Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	75,000 Added 16.67%	375,000 Class A Common Stock
Dec 31 2021	SELL Open market or private sale	$546,049 $43.32 p/Share	12,605 Reduced 4.03%	300,000 Class A Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$540,174 $43.58 p/Share	12,395 Reduced 3.81%	312,605 Class A Common Stock
Mar 03 2021	SELL Open market or private sale	$5,718,000 $38.12 p/Share	150,000 Reduced 31.58%	325,000 Class A Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	75,000 Added 13.64%	475,000 Class A Common Stock
Dec 30 2020	BUY Grant, award, or other acquisition	-	100,000 Added 20.0%	400,000 Class A Common Stock

Also insider at

LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC. Healthcare

> 10% Shareholder